SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001140361-24-030178
Filing Date
2024-06-14
Accepted
2024-06-14 16:06:00
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-1 ny20030990x1_s1.htm S-1 659414
2 EXHIBIT 5.1 ny20030990x1_ex5-1.htm EX-5.1 12776
3 EXHIBIT 23.1 ny20030990x1_ex23-1.htm EX-23.1 1876
4 FILING FEES TABLE ny20030990x1_ex107.htm EX-FILING FEES 20662
5 ny20030990logo.jpg GRAPHIC 34883
6 ny20030990logox1.jpg GRAPHIC 41540
7 ny20030990x1_logobro.jpg GRAPHIC 113027
  Complete submission text file 0001140361-24-030178.txt   956663
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-280215 | Film No.: 241044735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)